CYP2C8 polymorphism among the Portuguese.

Clin Chem Lab Med

Laboratory of Molecular Toxicology, Centre for Molecular and Structural Biomedicine (CBME), University of Algarve, Faro, Portugal.

Published: May 2006

Cytochrome P450 2C8 (CYP2C8) is a polymorphic phase I drug-metabolising enzyme involved in the metabolism of a wide variety of xenobiotics, as well as a proposed player in the regulation of vascular tone. Polymorphisms in this gene may have an impact on the metabolism of therapeutic drugs such as paclitaxel and verapamil. In this report we have determined the frequencies of the main non-synonymous CYP2C8 alleles, 805A>T (CYP2C8*2), 416G>A/1196A>G (CYP2C8*3) and 792C>G (CYP2C8*4) in a sample representative of Portuguese Caucasians. The allelic frequencies determined were 1.2%, 19.8%, and 6.4% for CYP2C8*2, CYP2C8*3, and CYP2C*4, respectively. The observed CYP2C8*3 prevalence is significantly different from the frequencies previously reported in North European populations.

Download full-text PDF

Source
http://dx.doi.org/10.1515/CCLM.2006.030DOI Listing

Publication Analysis

Top Keywords

cyp2c8 polymorphism
4
polymorphism portuguese
4
portuguese cytochrome
4
cytochrome p450
4
p450 2c8
4
2c8 cyp2c8
4
cyp2c8 polymorphic
4
polymorphic phase
4
phase drug-metabolising
4
drug-metabolising enzyme
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!